Predicting the Onset of AIDS

Slides:



Advertisements
Similar presentations
Changes In Protein Sequences Of the HIV-1 gp120 V3 Region In Non-Progressor Types Nicki S.Harmon Samantha M. Hurndon.
Advertisements

Wisconsin HIV/AIDS Surveillance Annual Review: Slide Set New diagnoses, prevalent cases, and deaths through December 2014 April 2015 P Wisconsin.
Genetic Similarities Between HIV-1 Viruses in the Onset of AIDS Isabel Gonzaga BIOL : Bioinformatics Laboratory Loyola Marymount University October.
PTP 560 Research Methods Week 4 Thomas Ruediger, PT.
Maximum Likelihood. Likelihood The likelihood is the probability of the data given the model.
A series converges to λ if the limit of the sequence of the n-thpartial sum of the series is equal to λ.
Series: Guide to Investigating Convergence. Understanding the Convergence of a Series.
Series: Guide to Investigating Convergence. Understanding the Convergence of a Series.
An Introduction to the HIV Problem Space Oakwood University: Faculty Quantitative Institute Aug. 10–12, 2009.
ACTG 333 The Antiviral Effect of Switching from Saquinavir to the New Formulation of Saquinavir vs. Switching to Indinavir After >1 year of Saquinavir.
Wisconsin Department of Health Services
Habil Zare Department of Genome Sciences University of Washington
Analysis of HIV Evolution Bobak Seddighzadeh and Kristoffer Chin Department of Biology Loyola Marymount University Bio February 23, 2010.
Wisconsin Department of Health Services HIV/AIDS Surveillance Annual Review New diagnoses, prevalent cases, and deaths through December 31, 2013 April.
Examining Subjects of HIV-1 With Possible Predominant Viral Strains Samantha Hurndon Isaiah Castaneda.
Copyright © 2011 Pearson Education, Inc. Publishing as Pearson Addison-Wesley Chapter 8 Sequences and Infinite Series.
1 Resistance and Tropism - Maraviroc Lisa K. Naeger, Ph.D. Division of Antiviral Products Food and Drug Administration April 24, 2007 FDA Antiviral Advisory.
The Human Genome Project & Pedigrees Chapter 11 & 12.
STEPHANIE HINTZEN BIOL 471 SIV and HIV: Differences in Diversity and Divergence.
Re evaluating the Categorization of HIV Progression in Subjects Based on CD4 T cell Decline Rates Angela Garibaldi & Ryan Willhite Loyola Marymount University.
A Mutational Investigation of an HIV Patient’s GP120 Glycoprotein and it’s Implications on CD4 Binding Salita Kaistha Usrinus College, Collegeville PA.
Predicting the Onset of AIDS Robert Arnold, Alex Cardenas, Zeb Russo LMU Biology Department 10/5/2011.
Patterns of selection for or against amino acid change among different CD4 T-cell count progressor groups Michael Pina, Salomon Garcia Journal Club Presentation.
Diversity and Divergence in HIV-1 Viral Variants between patients with high CD4+ T Cell Variability and Patients with Rapid CD4+ T Cell Decline Kevin Paiz-Ramirez.
Biostatistics in Practice Peter D. Christenson Biostatistician Session 6: Case Study.
Amino Acid Sequences in V3 Loop Conformation Alex Cardenas, Bobby Arnold and Zeb Russo Loyola Marymount University Department of Biology BIO /02/11.
Predicting the Onset of AIDS Robert Arnold, Alex Cardenas, Zeb Russo LMU Biology Department 10/5/2011.
Residue Sequence and Structure in the Re evaluation the Categorization of HIV Progression in Subjects Based on CD4 T cell Decline Rates Angela Garibaldi.
Changes In Protein Sequences Of the HIV-1 gp120 V3 Region In Non-Progressor Types Nicki S.Harmon Samantha M. Hurndon LMU Department of Biology BIOL 368.
Examining the Genetic Similarity and Difference of the Three Progressor Groups at the First and Middle Visits Nicole Anguiano BIOL398: Bioinformatics Laboratory.
Examining Genetic Similarity and Difference of the Three Progressor Groups at the First and Middle Visits Nicole Anguiano Bioinformatics Laboratory Loyola.
MTH 253 Calculus (Other Topics) Chapter 11 – Infinite Sequences and Series Section 11.5 – The Ratio and Root Tests Copyright © 2009 by Ron Wallace, all.
Geometric Sequence – a sequence of terms in which a common ratio (r) between any two successive terms is the same. (aka: Geometric Progression) Section.
Residue Sequence and Structure in the Re evaluation the Categorization of HIV Progression in Subjects Based on CD4 T cell Decline Rates Angela Garibaldi.
Examining Genetic Similarity and Difference of the Three Progressor Groups at the First and Middle Visits Nicole Anguiano BIOL398: Bioinformatics Laboratory.
Date of download: 6/3/2016 From: Report of the NIH Panel To Define Principles of Therapy of HIV Infection* Ann Intern Med. 1998;128(12_Part_2):
Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline Markham RB, Wang WC, Weisstein AE, Wang Z, Munoz A, Templeton A,
Date of download: 7/6/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effect of Antiretroviral Therapy on Viral Load, CD4.
Multiple Sequence Alignment Dr. Urmila Kulkarni-Kale Bioinformatics Centre University of Pune
Journal Club Presentation BIOL368/F16: Bioinformatics Laboratory
Learning objectives Define HIV treatment goals
Amino Acid Sequences in V3 Loop Conformation
Pipelines for Computational Analysis (Bioinformatics)
Measures of Association
Table 2. Mean intrasubject diversity for the 11 study participants, by genomic region. From: Hepatitis C Virus (HCV) Diversity in HIV-HCV-Coinfected Subjects.
The V3 Region Expresses More Diversity in Amino Acid Sequence in AIDS Diagnosed Patients than in Non-Trending and AIDS Progressing Patients HIV Structure.
Multiple Sequence Alignment
Do HIV+ Rapid Progressors Show More Divergence than Non-Progressors?
Amino Acid Sequences in V3 Loop Conformation
Ranking Tumor Phylogeny Trees by Likelihood
Ratio Test THE RATIO AND ROOT TESTS Series Tests Test for Divergence
Convergence or Divergence of Infinite Series
Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline Markham RB, Wang WC, Weisstein AE, Wang Z, Munoz A, Templeton A,
Investigations of HIV-1 Env Evolution
Loyola Marymount University
LMU Department of Biology
Predicting the Onset of AIDS
Loyola Marymount University
Amino Acid Sequences in V3 Loop Conformation
Қош келдіңіздер.
Wednesday, April 10, 2019.
Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline Markham RB, Wang WC, Weisstein AE, Wang Z, Munoz A, Templeton A,
Predicting the Onset of AIDS
Unit Genomic sequencing
Residue Sequence and Structure in the Re evaluation the Categorization of HIV Progression in Subjects Based on CD4 T cell Decline Rates Angela Garibaldi.
Determine whether the sequence converges or diverges. {image}
Chloe Jones, Isabel Gonzaga, and Nicole Anguiano
Survival based on V gene mutation status and CD38 expression among B-CLL patients who stratify to the Rai intermediate risk category. Survival based on.
Presentation transcript:

Predicting the Onset of AIDS Robert Arnold, Alex Cardenas, Zeb Russo LMU Biology Department 10/5/2011

Outline Bobby’s Part (5 slides) Zeb’s Part (5 slides) Alex’s Part (5 slides)

AIDS and CD4 counts CDC definition of AIDS is a CD4 count below 200 Once diagnosed, cannot be reversed Makes our first question irrelevant since all ‘rapid progressors’ drop below 200, AKA they all have AIDS

Development of two new questions Since we can tell who has AIDS, we would now like to determine whether there are any similar clones of the env gene across the AIDS subjects Does a median ds/dn ratio below 1.0 or lower determine whether you will get AIDS or not?

Our division of the Patients

Random clonal comparison To determine whether there were any similarities between clones of those who developed AIDS during the study and those at risk, we performed a ClustalW on a random selection of two clones from each subject

2 Clones Rooted Tree

Comparison of dS/dN Subject No. of observations CD4 Median intravisit nucleotide differences among clones Virus copy number (×103) Annual rate of CD4 T cell decline Slope of change in intravisit nucleotide differences per clone per year Slope of divergence (% nucleotides mutated from baseline consensus sequence per year) Median dS/dN AIDS   Subject 4 4 1,028 0.9 6.8 −593 4.64 2.09 Subject 10 5 833 1.71 99.3 −363 3.16 1 0.2 Subject 11 753 2.27 62.2 1.11 0.32 Subject 15 707 15.16 171 −362 −2.94 0.68 0.7 Subject 3 819 1.82 302.5 −294 0.53 0.74 Subject 1 3 464 5.64 307.6 −117 5.1 1.55 0.3 At Risk Subject 7 1,072 317.6 −392 −0.79 1.35 1.3 Subject 8 7 538 1.24 209 −92 1.68 1.16 0.5 Subject 9 8 489 9.49 265 −11 1.58 1.21 Subject 14 9 523 50.9 −51 1.69 0.6 Not at Risk Subject 2 715 1.64 21.6 30 1.32 0.49 1.8 Subject 5 749 2.5 260.6 −41 0.06 1.4 Subject 6 405 2.82 321.4 52 1.92 0.82 0.4 Subject 12 6 772 2.8 44 0.62 0.13 Subject 13 671 0.87 1.7 53 0.28 3.5

Neither Assumption is correct Using the original data from the Bedrock website, we determined who actually developed AIDS over the full study 1, 3, 4, 6, 7, 8, 9, 10, 11, 14, 15 Only 2, 5, 12 and 13 avoided the progression to AIDS over the course of the study

2 Clones Rooted Tree Redux

Comparison of dS/dN Subject No. of observations CD4 Median intravisit nucleotide differences among clones Virus copy number (×103) Annual rate of CD4 T cell decline Slope of change in intravisit nucleotide differences per clone per year Slope of divergence (% nucleotides mutated from baseline consensus sequence per year) Median dS/dN AIDS   Subject 4 4 1,028 0.9 6.8 −593 4.64 2.09 Subject 10 5 833 1.71 99.3 −363 3.16 1 0.2 Subject 11 753 2.27 62.2 1.11 0.32 Subject 15 707 15.16 171 −362 −2.94 0.68 0.7 Subject 3 819 1.82 302.5 −294 0.53 0.74 Subject 1 3 464 5.64 307.6 −117 5.1 1.55 0.3 At Risk Subject 7 1,072 317.6 −392 −0.79 1.35 1.3 Subject 8 7 538 1.24 209 −92 1.68 1.16 0.5 Subject 9 8 489 9.49 265 −11 1.58 1.21 Subject 14 9 523 50.9 −51 1.69 0.6 Not at Risk Subject 2 715 1.64 21.6 30 1.32 0.49 1.8 Subject 5 749 2.5 260.6 −41 0.06 1.4 Subject 6 405 2.82 321.4 52 1.92 0.82 0.4 Subject 12 6 772 2.8 44 0.62 0.13 Subject 13 671 0.87 1.7 53 0.28 3.5